S&P Futures
4,364.50 -14.25 (-0.33%) Dow Futures
34,179.00 -94.00 (-0.27%) Nasdaq Futures
14,877.50 -57.75 (-0.39%) Russell 2000 Futures
1,793.50 -7.40 (-0.41%) Crude Oil
89.35 -0.33 (-0.37%) Gold
1,933.50 -3.10 (-0.16%)
Pulse Biosciences, Inc. (6L8.F)
Chart Events
Performance Outlook
| Previous Close | 3.7800 |
| Open | 3.9000 |
| Bid | 3.8200 x 0 |
| Ask | 3.9400 x 0 |
| Day's Range | 3.9000 - 3.9000 |
| 52 Week Range | 1.3500 - 8.2000 |
| Volume | |
| Avg. Volume | 3 |
| Market Cap | 225.826M |
| Beta (5Y Monthly) | 1.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.0700 |
| Earnings Date | Nov 08, 2023 - Nov 13, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 38.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for 6L8.F
Related Research
Business WirePulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase
HAYWARD, Calif., September 07, 2023--Pulse Biosciences, Inc. (Nasdaq: PLSE, "the Company"), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced plans to participate at the upcoming Gilmartin Group Emerging Growth Showcase, taking place virtually. Members of management are scheduled to present on Thursday, September 21, 2023 at 10:30am PT.
Simply Wall St.We're Not Very Worried About Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Pulse Biosciences...
Business WirePulse Biosciences Clarifies Details of Recent S-3 Filing
HAYWARD, Calif., August 24, 2023--Pulse Biosciences, Inc. (Nasdaq: PLSE, "the Company"), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today provided additional clarification regarding the details of the SEC form S-3 ("the filing") filed August 11, 2023.
